secwatch.observer — SEC 8-K summary
======================================

Issuer:     Sonnet BioTherapeutics Holdings, Inc. (—)
CIK:        0001106838
Form:       8-K
Filed at:   2023-09-01T23:59:59+00:00
Accession:  0001493152-23-031408
Event type: other_material
Sentiment:  negative
Materiality: 0.65
Item codes: 3.03, 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Sonnet BioTherapeutics effects 1-for-22 reverse stock split effective August 31, 2023
--------------------------------------------------------------------------------

- Every 22 pre-split shares converted to 1 post-split share; no fractional shares issued, cash paid in lieu.
- Reverse split effective at 4:30 p.m. ET on August 31, 2023; trading on split-adjusted basis starts September 1.
- CUSIP number changed to 83548R303; par value and authorized shares unchanged.
- Stock options, warrants, and convertible securities adjusted proportionally.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1106838/000149315223031408/0001493152-23-031408-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1106838/000149315223031408/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-031408

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer